NASDAQ:ASBP | Balance Sheet | Aspire Biopharma Holdings, Inc.

Complete source-backed balance-sheet history.

Available history
2021-02-08 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$12.17M$288,450.00$13.47M$13.54M$972,108.00$1.69M$1.78M$11.76M
2026-03-31$5.86M$369,974.00$7.12M$7.12M$857,925.00$3.15M$3.25M$3.87M
2025-12-31$1M$253,160.00$1.31M$1.31M$1.01M$7.59M$7.69M-$6.38M
2025-09-30$1.95M$35,437.00$2.4M$2.4M$1.06M$13.86M$13.87M-$11.47M
2025-06-30$206,233.00$989,422.00$989,422.00$1.35M$10.56M$10.61M-$9.62M
2025-03-31$1.35M$1.97M$1.97M$1.43M$8.87M$8.92M-$7.95M
2024-12-31$3,633.00$147,989.00$147,989.00$310,219.00$1.69M$1.69M-$1.54M
2024-12-30-$1.54M
2024-09-30$16,541.00$61,809.00$6.66M$6.57M$6.57M-$774,378.00
2024-06-30$19,604.00$342,973.00$6.87M$6.24M$6.24M-$558,109.00
2024-03-31$47,287.00$65,577.00$20.2M$2.63M$2.63M-$489,747.00
2023-12-31$11,174.00$81,223.00$19.98M$403,328.00$403,328.00-$487,861.00
2023-12-30-$487,861.00
2023-09-30$280.00$253,362.00$19.89M$316,316.00$316,316.00-$62,954.00
2023-06-30$125,201.00$546,144.00$20.56M$284,356.00$284,356.00$261,788.00
2023-03-31$315,152.00$906,455.00$303.11M$356,421.00$11.17M-$10.26M
2022-12-31$497,259.00$1.1M$300.18M$303,323.00$11.12M-$9.94M
2022-09-30$533,129.00$1.15M$297.84M$188,705.00$11M-$9.62M
2022-06-30$579,751.00$1.21M$296.72M$146,466.00$10.96M-$9.37M
2022-03-31$618,122.00$1.26M$296.5M$51,756.00$10.86M-$9.05M
2021-12-31$293,221.00$293,221.00$293,696.00$293,696.00-$475.00
2021-09-30$280.00
2021-06-30$15,590.00
2021-03-31$17,973.00
2021-02-08$0.00